securities fraud

Class action filed against Franklin BSP Realty Trust alleging false statements about dividend sustainability. Investors who purchased shares between November 2024 and February 2026 may be eligible.

Class action lawsuit filed against $MNDY alleging materially false statements about revenue growth and concealed business deterioration.

Stellantis faces class action lawsuit alleging false statements on earnings forecasts, electrification strategy. Investors can join until June 8, 2026.

Law firm alleges Navan concealed 39% spike in sales and marketing expenses totaling $95M in Q3 2025 from IPO investors. Deadline to join lawsuit is April 24, 2026.

Apollo Global Management faces class action lawsuit for concealing executive communications with Jeffrey Epstein. Stock fell 16% during alleged fraud period.

Driven Brands faces securities fraud lawsuits over material accounting errors spanning 2023-2025. Stock fell 40% after disclosure; lead plaintiff deadline set for May 2026.

Super Micro Computer faces class action lawsuits after DOJ indicted three associates for illegally diverting $2.5B in AI servers to China, triggering 33% stock decline.

Trip.com faces securities fraud lawsuit after China's antitrust regulator probed alleged monopolistic practices. Stock fell 19.4% in January 2026.

ImmunityBio faces securities fraud lawsuit following FDA warning letter about misleading Anktiva advertisements. Stock fell to $7.42; investors have until May 26 to file claims.

RGNX faces class action lawsuit alleging false statements about RGX-111 safety. FDA clinical hold imposed after trial participant developed tumor.

NuScale Power ($SMR) faces securities fraud class action for allegedly misrepresenting ENTRA1 Energy's qualifications. Stock plunged 14.4% after $495M payment disclosure.

Law firm investigates Chanson International ($CHSN) for allegedly misleading shareholders; class action suit being prepared to recover investor losses.

Pomerantz LLP investigates Sempra for securities fraud after company missed $970M in revenue and cut guidance by $0.50/share, triggering 18.97% stock decline.

Pomerantz LLP filed class action against $IT for alleged securities fraud tied to two major stock declines. Investors have until May 18, 2026, to join the lawsuit.

Pomerantz Law Firm files class action suit against $RGNX after FDA clinical hold on gene therapy candidates triggers 17.9% stock collapse. Investor deadline: April 14, 2026.

Pomerantz Law Firm filed class action suit against $AMC over alleged securities fraud involving APE preferred equity holders excluded from special dividend. Investors must act by April 20, 2026.

PayPal shareholders targeted in class action alleging misstatements on Branded Checkout initiatives. Stock fell 20.3% following CEO replacement and disappointing earnings.

Law Offices of Howard G. Smith filed securities fraud class actions against $CHOW, $GO, $ALIT, $IT, alleging false statements on operations and finances. Investors must file lead plaintiff motions by mid-May 2026.

NuScale Power faces class action lawsuit alleging material misstatements about ENTRA1 partnership. Stock fell 12.4% post-disclosure; lead plaintiff deadline set for April 2026.

Franklin BSP Realty Trust shareholders pursue class action lawsuit after 14.2% stock plunge following dividend reset and disclosure of capital over-distribution to investors.